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Abstract: In golden retriever dogs, a 1 bp deletion in the canine TTC8 gene has been shown to cause
progressive retinal atrophy (PRA), the canine equivalent of retinitis pigmentosa. In humans, TTC8
is also implicated in Bardet–Biedl syndrome (BBS). To investigate if the affected dogs only exhibit
a non-syndromic PRA or develop a syndromic ciliopathy similar to human BBS, we recruited 10
affected dogs to the study. The progression of PRA for two of the dogs was followed for 2 years,
and a rigorous clinical characterization allowed a careful comparison with primary and secondary
characteristics of human BBS. In addition to PRA, the dogs showed a spectrum of clinical and
morphological signs similar to primary and secondary characteristics of human BBS patients, such as
obesity, renal anomalies, sperm defects, and anosmia. We used Oxford Nanopore long-read cDNA
sequencing to characterize retinal full-length TTC8 transcripts in affected and non-affected dogs,
the results of which suggest that three isoforms are transcribed in the retina, and the 1 bp deletion is a
loss-of-function mutation, resulting in a canine form of Bardet–Biedl syndrome with heterogeneous
clinical signs.
Keywords: Bardet–Biedl syndrome (BBS); primary cilia; ciliopathy; BBS8; progressive retinal atrophy
(PRA); retinitis pigmentosa
1. Introduction
Inherited retinal degenerations (IRDs) are a diverse group of retinopathies leading to visual
impairment and blindness in humans and other species. Most of the IRDs, such as retinitis pigmentosa
(RP) in humans (OMIM # 268000) and the canine equivalent, termed progressive retinal atrophy
(PRA), are non-syndromic and only affect vision. Syndromic IRDs are less common and besides visual
impairment, other organs are also affected. In golden retriever (GR) dogs with PRA, a 1 bp deletion
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in exon 7 of the Tetratricopeptide repeat domain 8 (TTC8) gene was identified in 2014 (CanFam3.1
Chr8:60,090,185delA, rs852355138, OMIA 001984-9615, here denoted as TTC8delA) [1]. This form of
PRA is generally referred to as GR-PRA2. The deletion was predicted to cause a frameshift of the
open reading frame leading to a premature stop codon in exon 8, 15 codons downstream of the
deletion. If translated, the truncated protein would lack most of the tetratricopeptide repeat motifs.
In humans, mutations in the TTC8 gene cause Bardet–Biedl syndrome (BBS; OMIM # 615985), a clinically
and genetically heterogeneous autosomal recessive ciliopathy and the second most common human
syndromic IRD after Usher syndrome [2,3].
BBS was first described by Georges Bardet and Artur Biedl in the early 1920s [4,5]. The symptoms
are highly variable, even between patients from the same family, and are divided into
primary and secondary characteristics [6,7]. Primary symptoms include retinal degeneration,
obesity, polydactyly, kidney abnormalities, learning disabilities or cognitive impairment,
hypogonadism in males, and genital abnormalities in females. Secondary features include speech
delay, developmental delay, behavioral abnormalities, eye abnormalities, brachydactyly/syndactyly,
ataxia/poor coordination/imbalance, short stature, mild hypertonia, diabetes mellitus, orodental
abnormalities, cardiovascular anomalies, situs inversus, hepatic involvement, craniofacial
dysmorphism, Hirschsprung disease, and anosmia [2,7,8]. For clinical diagnosis of BBS, it has been
suggested that four of the primary characteristics or alternatively three primary and two secondary
characteristics should be observed [8].
With 24 genes associated with BBS (OMIM # 209900) to date [9], the syndrome shows large
non-allelic heterogeneity [10–13]. The most common cause of the disorder in humans are mutations
in the BBS1 and BBS10 genes, each accounting for approximately 20% of human cases [14–16].
TTC8 mutations account for approximately 2% of the cases, being amongst the less frequent causes for
BBS [17]. In 2003, Ansley et al. discovered that the TTC8 gene is associated with BBS and identified
the syndrome as a basal body dysfunction of the ciliated cells [2]. The TTC8 gene, also referred to
as BBS8, is one of the eight BBS genes (BBS1, BBS2, BBS4, BBS5, BBS7, TTC8, BBS9, and BBIP1),
encoding proteins that assemble into a stable octameric protein complex termed the BBSome [18,19].
The BBSome forms a membrane coat that sorts membrane receptors to the primary cilium and its
dysfunction leads to the failure of cell-specific signal transduction affecting multiple cell-types and
organs [20].
In addition to pleiotropic disorder, there are also reports of non-syndromic retinal degeneration
caused by mutations in the BBS genes BBS1, BBS2, ARL6/BBS3, and TTC8 [21–24], disrupting the
normal function of photoreceptor cilia. At the time of the discovery of the canine TTC8 deletion in 2014,
there were indications that dogs homozygous for the deletion might exhibit clinical signs other than
retinal degeneration [1]. However, only ophthalmic examinations of the affected dogs were performed
and other BBS-associated characteristics could not be clinically investigated. In addition, it was not
possible to analyze tissues from affected individuals. Here, we describe a detailed examination of two
golden retrievers, homozygous for the TTC8 variant (TTC8delA) that were followed from the time of
the PRA-diagnosis until they were euthanized and a full necropsy was performed. This allowed for a
rigorous clinical characterization of this canine form of a TTC8-mediated disease, and to investigate
the effect of the canine TTC8 mutation on the transcriptional and protein level in the canine retina.
2. Materials and Methods
2.1. Animals and Samples
A golden retriever sib-pair, a male (GR01) and a female (GR02), was followed from the time of
their PRA-diagnosis until euthanasia, after which a necropsy was conducted and tissue samples were
collected. The male dog was 6 years and 1 month old, and the female was 3 months older at the time of
euthanization. Both dogs tested homozygous for the TTC8delA allele. Tissue samples were also collected
from five unaffected dogs (RW01, BE02, LR02, GS01, and GSP01) euthanized for reasons unrelated
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to this study (Table S1). In addition, two unaffected dogs (BE01 and LR01; Table S1) were included
in the clinical ophthalmic examination (see below). Interviews were conducted with owners of the
sib-pair, as well as the owners of eight additional affected golden retrievers, all tested homozygous for
the TTC8delA allele (Table S2). All samples were obtained with informed consent from the dog owners.
Ethical approval was granted by the regional animal ethics committee (Uppsala ethics committee on
animal experiments/Uppsala djurförsöksetiska nämnd; Dnr C12/15, Dnr 5.8.18-15533/2018, and Dnr
5.8.18-04682/2020).
2.2. Ophthalmic Examination, Confocal Scanning Ophthalmoscopy (cSLO), Optical Coherence Tomography
(OCT) and Electroretinography (ERG)
Ophthalmic examination of GR01 and GR02, as well as an unaffected beagle (BE01) and an
unaffected Labrador retriever (LR01) included reflex testing, testing of vision with falling cotton balls
under dim and daylight conditions, and tonometry (Tonovet, Icare Finland Oy, Vantaa, Finland),
as well as indirect ophthalmoscopy (Heine 500, Heine Optotechnik GmbH, Herrsching, Germany) and
slit-lamp biomicroscopy (Kowa SL-17, Kowa Company Ltd., Tokyo, Japan) after dilation of pupils with
tropicamide (Mydriacyl 0.5%, Alcon Nordic AS, København, Denmark).
cSLO- and OCT-imaging (Spectralis HRT + OCT, Heidelberg Engineering, Heidelberg, Germany)
were performed after dilation of pupils with tropicamide and under light sedation with 5 µg/kg
medetomidine (Sedator, Dechra Veterinary Products AB, Upplands Väsby, Sweden) and 50 µg/kg
butorphanol (Dolorex, Intervet AB, Stockholm, Sweden). The cornea was kept moist using artificial tears
throughout the procedure. Total retinal thickness in GR02 was measured as previously described [25],
and compared to data from an unaffected 5-year-old female Labrador retriever (LR01) and a 7-year-old
female beagle (BE01).
We recorded a bilateral, full-field ERG in GR02 under general anesthesia and compared to
data from the unaffected LR01. Sedation with intramuscular acepromazine 0.03 mg/kg (Plegicil vet.,
Pharmaxim Sweden AB, Helsingborg, Sweden) was followed by induction with propofol 10 mg/kg,
intravenously (Propovet, Orion Pharma Animal Health AB, Danderyd, Sweden). After intubation,
inhalation anesthesia was maintained with isoflurane (Isoflo vet., Orion Pharma Animal Health AB).
Corneal electrodes (ERG-JET, Cephalon A/S, Aalborg, Denmark) were used with isotonic eye drops
(Comfort Shield, i.com medical GmbH, Munich, Germany) as a coupling agent. Gold-plated, cutaneous
electrodes served as ground and reference electrodes (Grass, Natus Neurology Inc. Middleton, WI, USA)
at the vertex and approximately 3 cm caudal to the lateral canthi, respectively. Light stimulation,
calibration of lights, and processing of signals were performed as previously described [26] and the
ECVO protocol for canine clinical ERGs was followed [27].
2.3. Clinical Andrological Examination and Semen Analysis
Semen from the affected male (GR01, age 6 years and 1 month), was collected using digital
manipulation with a bitch in estrus present. The sperm concentration was measured using a Bürker
chamber. Sperm morphology was evaluated using standard procedures in wet preparations of semen
fixed in buffered formalin and in air-dried smears stained with carbolfuchsin–eosin. Due to a very low
sperm concentration and volume, only 50 spermatozoa were examined in the wet preparation, under a
phase-contrast microscope at 1000× magnification. All abnormalities on any given spermatozoon
were counted and the overall frequencies were classified according to a system developed by Bane
(1961) [28]. For a more detailed examination of the sperm heads, 100 spermatozoa were evaluated
in a smear under a light microscope at 1000× magnification. Presence of spermatogenic cells was
recorded in smears stained in accordance with standard well-established methodology. The head
morphologies were classified as pear-shaped, narrow at the base, abnormal contour, undeveloped,
loose and abnormal, narrow, and variable size.
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2.4. Echocardiography and Electrocardiographic (ECG) Examinations
For the echocardiographic examinations of the sib-pair (GR01 and GR02, at an age of 6 years
and 1 month), the dogs were placed in right and then left lateral recumbency on an ultrasound
examination table. The echocardiographic evaluation was conducted by use of an ultrasonographic
unit (EPIQ 7G, Philips Ultrasound, Bothell, WA, USA) equipped with a 5-1 matrix transducer and
ECG monitoring. The heart was examined and subjectively assessed in standard right- and left-sided
views [29]. Blood flow over heart valves was interrogated using color mode Doppler echocardiography
and measured using spectral Doppler echocardiography. Left ventricular dimensions were measured
using M-mode echocardiography in the right parasternal short axis view at the level of the papillary
muscles. The left atrial diameter was measured in the right parasternal short axis view at the level of the
aortic valve. Left ventricular dimensions were compared to published weight-based normal reference
ranges [30] and left atrial diameter was indexed to the aortic diameter as previously described [31].
2.5. Histopathological Examinations
Tissue samples from the affected siblings GR01 and GR02 (Table S3), as well as a retinal sample
from an unaffected 3-year-old Rottweiler (RW01), were fixed in 10% neutral buffered formalin for >24 h,
paraffin wax embedded, sectioned at 4 µm and stained with hematoxylin and eosin (HE). In addition,
kidney sections were also stained with periodic acid-Schiff (PAS). All sections were evaluated using
light microscopy.
2.6. Total RNA Extraction
The retinal tissue sample from the affected female GR02 was collected directly in TRIzol Reagent
(Invitrogen™, Carlsbad, CA, USA) for immediate RNA extraction. Retinal samples from three
unaffected dogs—a beagle (BE02), a Labrador retriever (LR02), and a German shepherd (GS01)—were
preserved in RNAlater (SigmaAldrich, Saint Louis, MO, USA) directly after euthanasia. The samples
were then washed with 1 × PBS and between 50 to 100 mg of tissue was used for extraction.
The samples from GR02, BE02, and GS01 were then homogenized in TRIzol Reagent with Precellys
homogenizer (Bertin Instruments, Montigny-le-Bretonneux, France) and total RNA was extracted
following the manufacturer’s instructions (Pub. No. MAN0001271, Rev. B.0.). Total RNA from LR02
was extracted with RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. RNA concentration was measured using Qubit RNA BR Assay kit (Invitrogen™,
Waltham, MA, USA). RNA integrity and quality were inspected with Agilent TapeStation 4150 with an
Agilent RNA ScreenTape (Agilent Technologies, Santa Clara, CA, USA). PolyA-selection was carried
out utilizing Dynabeads mRNA Purification Kit (Invitrogen™, Waltham, MA, USA), applying the
manufacturer-provided protocol.
2.7. Long-Read cDNA Sequencing with Oxford Nanopore Sequencing Technology (ONT)
Oxford Nanopore long-read cDNA sequencing libraries for the polyA-selected RNA of the canine
retina from the affected GR02 as well as unaffected BE02 and GS01 were prepared using the Direct
cDNA Sequencing kit (SQK-DCS109, Oxford Nanopore Technologies Ltd., Oxford, UK) following the
manufacturer’s instructions (Protocol version DCS_9090_v109_revC_04Feb2019; updated 02 May 2019).
The input material for each library was 100 ng of polyA-selected RNA. The prepared libraries were
sequenced on a MinION sequencer using R9.4.1 flow-cells and MinKNOW (v.19.06.7) software.
The resulting raw fast5 files were basecalled using Guppy version 3.1.5+781ed57 with the –trim_strategy
DNA flag. The quality control for each run was performed using an R markdown script developed
by ONT (Nanopore_SumStatQC_Tutorial.Rmd). To characterize the retinal TTC8 transcripts,
quality passed reads (quality score > 7) were mapped to the canine reference genome sequence
CanFam3.1 using MiniMap2 (v.2.16) with -ax splice parameter (Li, 2018) [32]. A reference-guided
assembly of the transcriptome was produced using StringTie2 (v.2.1.1) with default settings for
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long-reads (-L) [33], with Ensembl anotation build 100 (CanFam3.1). The assembled transcripts
were compared to the raw sequnce data using The Integrative Genomics Viewer (IGV) [34,35].
Transcripts with less then 20× coverage were discared. To quantify the expression levels, quality passed
reads (quality score > 7) were mapped to the canine reference transcriptome consisting of protein
coding gene sequences and non-coding RNA sequences from Ensembl build 100 (CanFam3.1) using
Minimap2 (v2.16) with the settings -ax map-ont -N 100 [32]. The transcript counts were produced using
Salmon (v.1.1.0) in aligned based mode and –libType A for automatic detection of library type [36].
The results for each transcript expressed as transcripts per million (TPM) were summarized to produce
gene level TPM values. We then analyzed the expression levels of genes considered to be expressed
in a cell-specific manner (retinal marker genes) [37–57]. The complete list of marker genes and their
respective references can be found in Table S4.
2.8. Quantitative RT-qPCR
cDNA was synthesized using RNA prepared from retinal samples of the affected female (GR02) and
three unaffected dogs (BE02, LR02, and GS01) using RT2 First Strand kit (Qiagen, Hilden, Germany) with
random hexamers provided in the kit. cDNA concentration was measured using Qubit ssDNA Assay
kit (Invitrogen™, Waltham, MA, USA). To amplify the target and the reference genes, custom primers
were designed using the software Primer3 [58,59] (Table S5). The cDNA fragments encoding regions of
interest were amplified using RT2 SYBR Green ROX qPCR Mastermix (Qiagen, Hilden, Germany) on a
StepOnePlus Real-Time PCR system (Applied Biosystems™, Waltham, MA, USA), according to the
manufacturer’s instructions. Target gene expression was normalized to expression of GAPDH as well
as ACTB reference genes, and shown relative to a control sample (BE02) (44CT method). The results
were confirmed in two independent experiments.
2.9. Fluorescence Histochemistry
Retina from the affected female (GR02) and an unaffected 10-year-old male German spaniel
(GSP01) were analyzed by means of fluorescence histochemistry. The lens and anterior segment were
removed and the vitreous punctured before the eye cups were fixed in 4% PFA in 1 × PBS for 15 min
on ice, washed in 1 × PBS for 10 min on ice, and cryoprotected in 30% sucrose in 1 × PBS at 4 ◦C
until saturated. The eye cups were embedded in Neg-50™ frozen section medium (Thermo Scientific,
Waltham, MA, USA) and 10 µm sections were collected on Superfrost Plus slides (J1800AMNZ,
Menzel-Gläser, Thermo Fisher Scientific, Waltham, MA, USA). Sections were re-hydrated in 1 × PBS for
10 min, incubated in blocking solution (1% donkey serum, 0.02% thimerosal, and 0.1% Triton X-100 in
1 × PBS) for 30 min at room temperature, and incubated in blocking solution containing Alexa Fluor™
488-conjugated PNA (1:400, L21409, Invitrogen™, Waltham, MA, USA) and a rhodopsin primary
antibody (1:5000, NBP2-25160, Novus Biologicals, Abingdon, UK) overnight at 4 ◦C. The sections
were then washed in 1 × PBS, 3 × 5 min, incubated in Alexa 568 secondary antibody (1:2000,
A10037, Invitrogen™, Waltham, MA, USA) for at least 2 h at room temperature, washed in 1 × PBS,
3 × 5 min, and the slides mounted using ProLong™ Gold Antifade Mountant with DAPI (P36931,
Molecular Probes, Waltham, MA, USA). Images were captured using a Zeiss Imager.Z2 microscope
equipped with an Axiocam 512 mono camera (Carl Zeiss Microscopy GmbH, Jena, Germany).
3. Results
3.1. Desciption of Primary and Secondary Bardet-Biedl Syndrome Characteristics
To investigate if the dogs exhibit other BBS-related problems, we interviewed the owners of 10
affected dogs. Two of the dogs were also part of the 2014 study [1], and we based the interviews
on the questionnaire developed by Downs et al. (2014) [1]. Among the 10 affected dogs, 4 were
reported to exhibit a minimum of four characteristics matching human primary BBS-signs (Table S2).
The remaining dogs displayed three (two dogs) and two (three dogs) primary signs, respectively,
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and for one dog, PRA was the only reported primary characteristic. All of the dogs had been diagnosed
with PRA, and the average age of diagnosis was 4 years and 8 months. None of the dogs were reported
to have polydactyly or any other malformations of the paws, but obesity or polyphagia, renal problems,
cognitive dysfunction, irregular estrous cycles, and decreased libido in males were among the reported
primary signs. As for secondary BBS signs, many dogs were described to have a short stature relative
to the standard for the breed. Partial or complete loss of the sense of smell (anosmia), worsening with
age, was noticed by most of the owners (Table S2). Half of the individuals were also diagnosed with
cataracts. At the time of this study, seven of these dogs were no longer alive. The oldest dog was
reported to have died in his sleep at 10 years of age, while the other dogs had been euthanized at an
average age of 7.5 years. Among the dogs in the questionnaires was the BBS-affected sib-pair (GR01
and GR02), which were further investigated in this study.
3.2. Ophthalmic Examinations of the Affected Sib-Pair
The male dog GR01 was initially diagnosed with PRA at the age of 4 years and 3 months, after
which he and his female littermate GR02 were genotyped and found to be homozygous for the TTC8delA
allele and subsequently recruited for this study. The two dogs were then examined ophthalmologically
on three occasions: at the age of 4.5 and 5.5 years, and finally at the age of 6 years and 1 month. At the
first examination, both dogs had mildly dilated pupils in room light. Pupillary light reflexes and
menace responses were considered normal, but the dazzle reflex was mildly impaired in both eyes
(oculi uterque, OU). The results of the cotton ball test in room light were unremarkable for both dogs,
whereas the female detected approximately 50% and the male only between 10–20% of the cotton balls
under dim light conditions. On indirect ophthalmoscopy, generalized abnormal tapetal reflection going
from hypo- via normo- to hyperreflection (in the male) was seen when the indirect ophthalmoscopy
lens was tilted back and forth. Furthermore, retinal vascular attenuation and pigment clumping in
the non-tapetal fundus were observed. Compared to the female dog, the male showed signs of more
advanced retinal degeneration. Findings were symmetrical between eyes. In addition to the abnormal
retinal appearance, equatorial and anterior cortical cataracts were seen in the eyes of both individuals.
The male had multiple, pigmented iridociliary cysts mainly emerging through the nasal portion of the
pupils (OU), but free-floating and collapsed cysts were also seen in the anterior chambers. Intraocular
pressures (IOP) were normal (OU) in both dogs.
To further investigate the retinal phenotype, we performed cSLO and OCT on the affected female
(GR02). Reduced fundus autofluorescence (FAF) in the entire tapetal fundus was seen on cSLO
(Figure 1a), whereas the non-tapetal fundus appeared slightly hyperreflective indicating accumulation
of lipofuscin in the degenerating retina. Retinal vascular attenuation in the affected fundus was
evident, as well as islets with bright tapetal hyperreflection (Figure 1b), compared to the unaffected
dog (Figure 1c,d).
Genes 2020, 11, 1090 7 of 27
Genes 2020, 11, x FOR PEER REVIEW 7 of 28 
 
 
Figure 1. Fundus autofluorescence (FAF) and infrared confocal scanning laser ophthalmoscopy (IR-
cSLO). cSLO FAF- and IR-cSLOs of the left eye of GR02 (panels (a,b), respectively) and age-matched, 
unaffected Labrador retriever LR01 (panels (c,d), respectively). Both FAF-images are inverted and 
hence, the tapetal reflection in GR02 (a) is remarkably faint. Detection of FAF in the tapetal fundus is 
difficult because of the normal, bright reflection from the tapetum lucidum. Black arrows indicate 
areas with bright reflection in the tapetal fundus on FAF (a), but hyporeflection on IR (b), which is 
suggestive of lipofuscin accumulation. The slight hyperreflection (the grey shade below the optic 
nerve head in the inverted image) (a) in the non-tapetal area autofluorescence indicates storage of 
lipofuscin. The IR-image (b) shows the large, myelinated optic nerve head often seen in the golden 
retriever breed, but very attenuated retinal vessels (red arrows) and islets of hyperreflectivity. Cast 
shadows in the cSLOs from GR02 were caused by the cataracts present in this dog (one shadowed 
area indicated by the blue oval). 
OCT showed considerable retinal thinning (Figure 2a) compared to two unaffected dogs (LR01 
and BE01). Mainly the outer retinal layers were reduced in thickness and outer retinal landmarks, 
such as the external limiting membrane (ELM), ellipsoid zone (EZ), and interdigitation zone (IZ), 
could not easily be identified in the affected dog (Figure 2b). The inner nuclear layer (INL) was thin 
and often fragmented, making the segmentation of the outer plexiform layer (OPL) and inner 
plexiform layer (IPL) difficult. In the ventral (inferior) non-tapetal fundus, retinal thickness was also 
reduced, but more irregularly, giving a patchier appearance. Again, segmentation of the outer retinal 
layer on the OCT image was difficult and a distinct outer nuclear layer ONL occasionally missing. 
Both fragmentation and thickening of the retinal pigment epithelium (RPE)was observed (Figure 2c). 
The cataracts in the male (GR01) hindered the cSLO and OCT examinations. 
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CT showed considerable retinal thinning (Figure 2a) compared to two unaffected dogs (LR01 and
BE01). Mainly the outer retinal layers were reduced in thickness and outer retinal landmarks, such as
the external limiting membrane (ELM), ellipsoid zone (EZ), and interdigitation zone (IZ), could not
easily be identified in the affected dog (Figure 2b). The inner nuclear layer (INL) was thin and often
fragmented, making the segmentation of the outer plexiform layer (OPL) and inner plexiform layer
(IPL) difficult. In the ventral (inferior) non-tapetal fundus, retinal thickness was also reduced, but more
irregularly, giving a patchier appearance. Again, segmentation of the outer retinal layer on the OCT
image was difficult and a distinct outer nuclear layer ONL occasionally missing. Both fragmentation
and thickening of the retinal pigment epithelium (RPE)was observed (Figure 2c). The cataracts in the
male (GR01) hindered the cSLO and OCT examinations.
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and a Beagle (BE01). (b) OCTs from the nasal part of the fundus (red rectangles) from the affected dog 
(GR02, top) and the unaffected dog (LR01, bottom) showing both the marked thinning of the outer 
nuclear layer (ONL) (asterisk) and less distinct segmentation of retinal layers in the affected dog. (c) 
Appearance of the retina in the non-tapetal, ventral fundus of GR02. The vertical red bar in the cSLO-
image shows the area outlined by the red rectangle on the OCT photograph, which is then magnified 
below (the area inside the large red rectangle). Cast shadows on the cSLO-image were caused by 
cataracts. The thinned retina is more variable in thickness than in the tapetal fundus dorsal to the 
ONH. The retinal pigment epithelium (RPE) is occasionally fragmented (red arrows) or appears 
thickened (blue arrows). The segmentation of the outer retina is difficult and dark areas probably 
representing clusters of nuclei in the ONL are seen occasionally (white arrows). 
Flash-electroretinography (FERG) was performed in the female, but not in the male, because of 
the ophthalmoscopic signs of more advanced retinal degeneration. In the female, rod responses were 
non-detectable throughout the 20 min dark adaptation. Neither was the a-wave of the mixed, dark-
adapted rod-cone response discernible and the b-wave had profoundly subnormal amplitude and 
was dominated by the early, mainly cone-driven part. The light-adapted cone-driven transient b-
wave was relatively better preserved, but biphasic with a late, second peak, whereas the a-wave was 
Figure 2. Retinal thickness and optical coherence tomography (OCT). (a) Total retinal thickness
temporally from the optic nerve head (ONH) towards the periphery of the retina is reduced in the
affected dog (GR02) compared to the thickness observed in an unaffected Labrador retriever (LR01)
and a Beagle (BE01). (b) OCTs from the nasal part of the fundus (red rectangles) from the affected
dog (GR02, top) and the unaffected dog (LR01, bottom) showing both the marked thinning of the
outer nuclear layer (ONL) (asterisk) and less distinct segmentation of retinal layers in the affected
dog. (c) Appearance of the retina in the non-tapetal, ventral fundus of GR02. The vertical red bar
in the cSLO-image shows the area outlined by the red rectangle on the OCT photograph, which is
then magnified below (the area inside the large red rectangle). Cast shadows on the cSLO-image were
caused by cataracts. The thinned retina is more variable in thickness than in the tapetal fundus dorsal
to the ONH. The retinal pigment epithelium (RPE) is occasionally fragmented (red arrows) or appears
thickened (blue arrows). The segmentation of the outer retina is difficult and dark areas probably
representing clusters of nuclei in the ONL are seen occasionally (white arrows).
Flash-electroretinography (FERG) was performed in the female, but not in the male, because of
the ophthalmoscopic signs of more advanced retinal degeneration. In the female, rod responses
were non-detectable throughout the 20 min dark adaptation. Neither was the a-wave of the mixed,
dark-adapted rod-cone response discernible and the b-wave had profoundly subnormal amplitude
and was dominated by the early, mainly cone-driven part. The light-adapted cone-driven transient
b-wave was relatively better preserved, but biphasic with a late, second peak, whereas the a-wave was
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essentially missing. The cone flicker response was more abnormal, as the cone-driven responses were
unable to follow the 30 Hz stimuli (Figure 3).
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was severely visually impaired both under daylight and dim light conditions, and had developed 
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Figure 3. Flash-electroretinographs (FERGs). Both dark-adapted (DA) and light-adapted (LA) responses
of the FERG had subnormal amplitudes in the affected golden retriever (GR02; red tracings) compared to
the unaffected Labrador retriever (LR01) (blue tracings). Rod responses were essentially non-detectable
and even the dark-adapted responses to the bright rod-cone stimulus seem to be mainly cone-driven.
Light-adapted cone transients lacked a-wave and had a biphasic waveform. When a 30 Hz stimulus
was employed, the cone responses of GR02 came out of sync and were not time-locked to the individual
stimuli. Calibrations show the time base and the different amplitude scales for GR02 and LR01.
The siblings were re-examined 11 months later at the age of 5.5 years. Pupils were now moderately
to widely dilated in both dogs, pupillary light reflexes sluggish and incomplete, and dazzle reflexes
impaired. The male dog showed poor menace responses and did not respond to falling cotton
balls regardless of lighting, but did occasionally follow hand movements at 30 cm in bright light.
Vision was less impaired in the female; menace responses were retained and approximately 50% of
the falling cotton balls were perceived in room light, whereas no cotton balls were detected in dim
light. Ophthalmoscopy showed generalized tapetal hyperreflection in both dogs with a brighter
hyperreflection in the male than in the female. Retinal vascular attenuation was now moderate to
advanced and the optic nerve heads appeared pale. In the non-tapetal area, pigment clumping was
observed, as on the previous examination. Cataractous changes had progressed in both dogs and
were seen in both the anterior and posterior cortices of both eyes, as well as in the equatorial region.
Iridociliary cysts were still present in the male and his eyes were normotensive.
Both dogs were examined a third time at the age of 6 years and 1 month. At this time, the male
was severely visually impaired both under daylight and dim light conditions, and had developed
bilateral mature-hypermature total cataracts. In addition, the dog showed both intact and ruptured
iridociliary cysts bilaterally (Figure 4a) and had normal IOP. However, the ocular fundi could not
be examined in vivo because of the cataracts. Postmortem gross examination of the fundi revealed
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bright hyperreflection in the tapetal area (Figure 4b). The network of retinal blood vessels was severely
attenuated (even for a postmortem specimen) and difficult to follow towards the periphery (Figure 4b).
The pupils of the female dog (GR02) were dilated in room light conditions, the pupillary light reflexes
(PLRs) were sluggish and incomplete, dazzle reflexes were poor, and menace responses were present
in room light, but not in dim light conditions. The female was unable to detect falling cotton balls
regardless of lighting. The cataractous changes had progressed (OU), particularly in the posterior than
in the anterior cortex, and the tapetal hyperreflectivity and retinal vascular attenuation could now only
be seen like through a haze.
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3.3. Andrological Exa ination
The testes of the affected ale dog R01 ere both palpable in the scrotu and found to be
s aller than nor al for the age and breed. n ejaculate of a very s all volu e (<0.5 L), and light
grey in color, was obtained. The sperm concentration was 15 × 106/mL and motility was <5%. The total
sperm count could not be calculated exactly, but was estimated to be <7 × 106/mL. There was a high
proportion of spermatozoa with abnormalities, and less than 1% were considered morphologically
normal. Midpiece defects were predominant (82% of spermatozoa), consisting of “Dag defect” [60],
with strong folding, coiling, and fracture of the distal part of the midpiece, and “tail stump defect”,
where, in place of normal tails, short “stu ps” were found. Other defects were coiled tails (12%),
and double bent tails (6%), as well as proximal droplets (12%), acrosome defects (4%), and nuclear
pouches (20%). Head defects were detected in 36% of the spermatozoa, the most common being pear
shaped (11%), variable size (10 ), and loose abnormal heads (7%). In addition, a large number of
spermatogenic cells, inflammatory cells, and epithelial cells, as well as necrotic cells of varying sizes,
were present (Figure 5a).
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Figure 5. Light microscopy of sperm and seminiferous tubules from the affected male (GR01).
(a) Papanicolaou staining of semen showing several abnormal spermatozoa. Different tail defects are
evident, including coiled tails (C), tail stumps (*) and loose heads (L). S: spermatogenic cell, N: neutrophil
leukocyte. (b) Tubuli seminiferi in testis stained with hematoxylin and eosin, showing mainly early
stages of spermatogenesis and few elongated spermatids (ES).
3.4. Cardiac Examination
Both dogs (GR01 and GR02) presented normal respiratory sinus arrhythmia at a normal heart rate
(between 80–90 BPM). Echocardiography showed normal cardiac morphology, dimensions, and motion
in both dogs. Minimal regurgitation over the mitral valve was detected in both dogs, but valve
morphology appeared normal. None of the dogs manifested situs inversus.
3.5. Necropsy Findings
To further investigate clinical features associated with BBS, a thorough necropsy was conducted
on both affected dogs. The body condition score (BCS) of the male (GR01) was estimated to be
9/9, consistent with obesity [61]. In gross examination of the male, an abnormal head shape with
a broadened muzzle and flat forehead was perceived, as was a low withers height. Furthermore,
there was gingival hyperplasia and moderately increased interdental spaces (diastema) in both lower
and upper jaw. The testicles were also seemingly small for the dog’s breed and age. Gross examination
of the kidneys revealed suspected chronic infarcts bilaterally, with the most marked changes in the
right kidney (Table S3). Mild myxomatous valvular degeneration was seen in the heart of the affected
male. The body condition score (BCS) of the female (GR02) was assessed to be 7/9, consistent with
heavy [61]. The interdental spaces were also moderately increased. The kidneys showed signs of mild
chronic glomerulonephritis bilaterally (Table S3).
3.6. Histopathology Findings
Next, we examined the histopathology of tissue samples collected during the necropsy.
Abnormal changes were observed in the retina, kidney, and testis. The majority of the retina
from the male (GR01) exhibited severe retinal thinning with complete loss of normal architecture
with most pronounced degenerative changes in the non-tapetal fundus. Compared to a normal retina
(Figure S1a), the ONL of the affected male GR01 was severely affected in the tapetal fundus and
completely missing in the non-tapetal fundus (Figure S1b,c).
Histopathological examination of the testicles revealed only few (or no) late spermatids in the
tubuli seminiferi (Figure 5b). A reduced number of spermatocytes was also observed. Microscopically,
sections from the lesions in the right kidney of the male (GR01) corresponded to segmental areas of
fibrosis, infiltrated by a moderate number of lymphocytes and plasma cells, extending from cortex to
medulla (Figure 6a,b). In the fibrotic tissue, there were some degenerated glomeruli and lack of tubular
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structures. Furthermore, a disarray of occasional small glomeruli with peripheral nuclei and inapparent
capillaries (fetal glomeruli), as well as atypical tubular structures outlined by pseudostratified cuboidal
epithelium with large, basophilic, plump cells, were seen. No cellular atypia or mitotic activity were
evident. Occasional dilated tubular structures were seen (Figure 6b). No chronic infarcts were
confirmed histologically in the left kidney. On microscopic examination of the kidneys from the female
(GR02), changes consistent with mild chronic glomerulonephritis was evident.
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GS01 11,717,598 9.01 7,629,750 (65.1%) 7.06 (78.4%) 926 1135 9.5 
* Gb of DNA sequence. 
The cDNA sequence data was assembled into transcripts using reference-guided assembly. The 
predicted transcripts of the TTC8 gene were then manually curated with the raw sequence data. We 
could not assemble any full-length TTC8 transcripts from the sample of the affected dog (GR02) due 
to lack of read coverage over the TTC8 locus. In contrast, sequence data from the unaffected dogs 
(BE02 and GS01) suggested transcription of three different retinal isoforms at the TTC8 gene, here 
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kidney stained with hematoxylin and eosin, showing a segmental area of fibrosis, (a) infiltrated by
lymphocytes and plasma cells, extending from cortex, with the presence of a disarray of atypical
tubular structures, and (b) with occasional small glomeruli with peripheral nuclei and inapparent
capillaries (fetal glomeruli, marked with an arrow). Furthermore, multiple degenerated glomeruli are
seen (arrowheads).
3.7. Characterization of Canine TTC8 Transcripts in the Retina
To comprehensively characterize the different TTC8 transcripts expressed in the canine retina and
to investigate the effect of the 1 bp deletion (TTC8delA) in an affected dog, we performed full-length
cDNA sequencing of the neural retina from the female (GR02), as well as of two 12-year-old unaffected
female dogs, a beagle (BE02) and a German shepherd (GS01), using Oxford Nanopore Technologies
(ONT) for long-read sequencing. This produced 3.6 M reads and 5.86 Gb of quality p ssed DNA
sequence for GR02, 7.8 M reads and 10.68 Gb for BE02, as well as 7.6 M reads and 7.06 Gb for GS01
(Table 1).
Table 1. Full-length cDNA sequencing (ONT).
Dog ReadsProduced
Bases
Called *
Quality Passed
Reads
Quality Passed
Bases *
Mean Read
Length (bp)
N50
(bp)
Mean Read
Quality
GR02 4,895,849 6.78 3,577,000 (73.1%) 5.86 (86.3%) 1637 2277 10.1
BE02 10,284,735 12.36 7,819,514 (76%) 10.68 (86.4%) 1365 1756 10.6
GS01 11,717,598 9.01 7,629,750 (65.1%) 7.06 (78.4%) 926 1135 9.5
* Gb of DNA sequence.
The cDNA sequence data was assembled into transcripts using reference-guided assembly.
The predicted transcripts of the TTC8 gene were then manually curated with the raw sequence data.
We could not assemble any full-length TTC8 transcripts from the sample of the affected dog (GR02) due
to lack of read coverage over the TTC8 locus. In contrast, sequence data from the unaffected dogs (BE02
and GS01) suggested transcription of three different retinal isoforms at the TTC8 gene, here denoted tr1,
tr2, and tr3 (Figure 7a). Fourteen exons were detected in tr1, 15 in tr2, and 16 in tr3, comprising 6.5%,
76.1%, and 17.4% of the TTC8 transcripts, respectively. In tr1, exons 1b and the retinal specific exon 2a
were missing. In tr2, exon 1b was absent, whereas tr3 featured both exons 1b and 2a. The comparison
of the identified transcripts to existing annotations showed that the exon-intron boundaries and
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sequence between the first and the last exon of tr1 corresponds to the curated NCBI RefSeq transcript
NM_001284469.1, tr2 corresponds to the predicted NCBI RefSeq transcript XM_003639207.4, as well
as Ensembl transcript ENSCAFT00000027700.5, and tr3 corresponds to the predicted NCBI RefSeq
transcript XM_014115661.2. The exon-intron boundaries of the identified transcripts show similarity
to human TTC8 transcripts (Figure 7b). In all three transcripts, a putative translation initiation site
(TIS) was identified in exon 1 (Chr8:60,061,732) containing an AUG start codon with an adjacent
optimal (GCCRCCAUGG) Kozak consensus sequence (Figure 7a) [62,63]. Using the TIS, tr1 and tr2
have an open reading frame extending to the last exon, encoding for 505 and 515 aa protein products,
respectively. However, in tr3, the TIS would lead to a termination codon two exons downstream of
exon 1, producing a 49 aa protein product and would lack the tetratricopeptide repeat (TPR) motifs.
An alternative TIS is found at position Chr8:60,077,223 of exon 2 and, although the adjacent Kozak
consensus is not optimal, it is classified as strong (NNNRNNAUGG) [63]. This alternative TIS is
in-frame with the original coding sequence, and its open reading frame would produce a 455 aa
protein product for all three transcripts, including the TPR motifs (Figure 7a). We did not observe
any transcripts skipping exon 7, where the deletion Chr8:60,090,185delA is located, nor any exons
downstream the deletion.Genes 2020, 11, x FOR PEER REVIEW 14 of 28 
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location of the TPR motifs, and below, the three identified canine retinal transcripts. The black dashed
lines indicate the two alternative TIS including the Kozak consensus sequence, and the translation
termination site in exon 14. The red dashed lines indicate the 1 bp deletion of adenine in exon 7 and
the premature stop codon in exon 8. (b) An overview of identified human TTC8 coding variants (red
dashed line) and splice-site variants (blue dashed line), see Table S6. The positions of the human
mutations are based on the reported positions in the original publications, and the exon numbering
may therefore differ from the positions in the presented transcript (ENST00000345383.9). tr1: transcript
1, tr2: transcript 2, tr3: transcript 3, TPR: tetratricopeptide repeat, TIS: translation initiation site.
Next, we compared TTC8 gene expression levels of the unaffected BE02 and GS01 with the
TTC8 levels of the affected GR02 with 1 bp deletion in the exon 7 (Figure 8). We first estimated the
transcript abundance for each annotated gene with Salmon (v.1.1.0) [36] using canine transcriptome
from Ensembl build 100 and then summarized the level of transcript expression of each gene in the
annotation. In BE02, the TTC8 gene was expressed at a level of 99.8 transcripts per million (TPM)
(856th most highly expressed gene), and in GS01 at a level of 60.6 TPM (859th most highly expressed
gene). As suggested by the low read coverage of GR02 of TTC8 transcripts, the expression levels were
low in the affected dog, with 16.8 TPM (3625th most highly expressed gene). We then summarized
the expression levels of known marker genes for different cell types in the retina (Table S4, Figure 8).
The expression of genes transcribed in the rod photoreceptor cells (PDE6A, PDE6B, CNGB1, CNGA1,
and GNAT1) [39,43,64–66] accounted for 25–27% of the total marker gene expression (TPM) in both
the unaffected dogs (Figure 8a,b). For the affected GR02, the expression was estimated to 0.2%,
indicating that the sample only included a small fraction of rod cells compared to the unaffected
dogs (Figure 8c). The rhodopsin gene (RHO), encoding for a specialized G protein-coupled receptor
known to be expressed exclusively in rod photoreceptors, was not included in the most recent Ensembl
annotation release (build 100) used in the analysis, and therefore not included in the rod marker gene
list. Similarly, the POU Class 4 Homeobox 1 (POU4F1), marker for retinal ganglion cells [67], was not
among the genes annotated in Ensembl build 100. Both RHO and POU4F1 were instead included in the
quantification using reverse transcription quantitative real-time PCR (see below). The expression levels
of cone photoreceptor cell markers (ARR3, GUCA1C, PDE6C, PDE6H, and OPN1LW) [37–43] were also
lower in GR02, whereas the expression levels of macroglial cell (MG) marker genes (RLBP1, SLC1A3,
GLUL, CLU, and GFAP) [43–46] were elevated (Figure 8a–c). The marker gene expression levels of
the horizontal cells (HC) [47,48], retinal ganglion cells (RGC) [49–54], RPE cells [50,55], amacrine cells
(AC) [47,56], or bipolar cells (BC) [57] did not differ drastically between the three dogs, although the
proportional expression of BC and RPE markers was higher in the affected female. The complete list of
marker genes and their expression values in each sample can be found in Table S4.
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Figure 8. Expression of retinal marker genes. (a) The average expression of marker genes for each retinal
cell type in the unaffected BE02 (a) and GS01 (b) dogs as well as the affected GR02 (c), based on cDNA
sequencing. (d) Relative mRNA expression levels by quantitative RT-qPCR in two different regions
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(exons 7–8 and exons 13–14) of the TTC8 gene, as well as the retinal marker genes GFAP (macroglial cells),
OPN1LW and OPN1SW (cone photoreceptors), RHO (rod photoreceptors), RPE65 (RPE cells), and POU4F1
(retinal ganglion cells) expression in three unaffected dogs (BE02, LR02, GS01) and the affected GR02,
normalized to GAPDH and ACTB gene expression. Rod: rod photoreceptors, cone: cone photoreceptors,
RGC: retinal ganglion cells, AC: amacrine cells, HC: horizontal cells, BC: bipolar cells, MG: macroglial
cells, RPE: retinal pigment epithelium, BE02: unaffected beagle, GS01: unaffected German shepherd, GR02:
affected golden retriever, LR02: unaffected Labrador retriever.
To verify the relative differences in the expression levels of TTC8 and retinal marker genes in the
affected GR02 and unaffected BE02 and GS01, as well as in an unaffected Labrador retriever (LR02,
not used in the cDNA sequencing), we performed reverse transcription quantitative real-time PCR
(RT-qPCR). We amplified two separate regions of the TTC8 gene over the exons 7 to 8 and 13 to 14
(Figure 8d). In addition, we amplified canine long-wave (OPN1LW), and short-wave (OPN1SW) opsins
expressed in cone photoreceptors, as well as, retinoid isomerohydrolase RPE65 (RPE65) and glial
fibrillary acidic protein (GFAP) genes (markers for RPE cells and macroglia, respectively) to compare
their cDNA sequencing levels to RT-qPCR. We also used RHO to evaluate relative rod photoreceptor
levels and POU Class 4 Homeobox 1 (POU4F1) to evaluate retinal ganglion cells in these retinal
samples. With the exception of RPE65 expression, the RT-qPCR results reflected the cDNA sequencing
quantification showing that the expression of both TTC8 amplicons, as well as RHO expression,
were lower in the GR02 compared to the three unaffected dogs and GFAP expression was higher than
in the unaffected dogs (Figure 8d).
3.8. Fluorescence Histochemical Analysis of the TTC8delA Retina
RT-qPCR analysis revealed low expression of markers of rod and, to a lesser extent,
cone photoreceptors in the affected female (GR02; Figure 8), and the histopathology analysis for
the affected male (GR01; Figure S1) and OCT analysis for the affected female (GR02; Figure 2) showed
that both the ONL and photoreceptor layer were thinner compared to control retinas. To investigate
the presence of photoreceptors in the TTC8delA retina, we performed fluorescence histochemistry
using an antibody directed against rhodopsin and fluorophore-conjugated peanut agglutinin (PNA),
which binds selectively to cone photoreceptors in the retina [68]. Retinal sections from an unaffected,
10-year-old German spaniel (GSP01) and the affected, 6-year-old female golden retriever (GR02) were
analyzed (Figure 9). We found that the ONL and the photoreceptor layer were thinner in the GR02
retina compared to control. In the unaffected retina, both rhodopsin and PNA staining were found
in the photoreceptor layer (Figure 9a), whilst in the affected GR02 retina, rhodopsin staining was
absent and PNA labeled what appeared to be truncated cone outer segments in the photoreceptor layer
(Figure 9b). The fluorescence data corroborate the histopathology and OCT findings.
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that of the unaffected dog. PNA: peanut agglutinin, ONL: outer nuclear layer, INL: inner nuclear 
layer, GCL: ganglion cell layer. Scale bar: 50 µm and applies to both images. 
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(generally referred to as GR_PRA2) may indeed be similar to Bardet–Biedl syndrome (BBS) in 
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syndrome, which may in fact, to some extent be considered a variation of the same condition [69]. 
Figure 9. Fluorescence histochemistry of dog retinas for rhodopsin and cone photoreceptors.
Fluorescence micrograph showing rhodopsin expression (red), Alexa™ 488-conjugated PNA (green),
and DAPI (blue) in (a) a male, unaffected, 10-year-old German spaniel (GSP01) and (b) a female,
affected, 6-year-old golden retriever (GR02). t t e thin ONL, lack of rh dopsin staining, and the
truncated cone outer segments (exemplifie ro heads) in the retina of the affected compared
that of the unaffected dog. PNA: peanut agglutinin, ONL: outer nuclear layer, INL: in er nuclear layer,
GCL: ganglion cell layer. Scale bar: 50 µm and applies to both images.
4. Discussion
When the deletion at the 8 locus (TTC8delA) in golden r trievers was discovered in 2014,
there were indications that the mutation did not only lead to progressive retinal degeneration in
the affected dogs, but could also cause additional clinical signs, suggesting a syndromic type of
disease [1]. However, at the time, no cases were available for a thorough clinical examination apart
from ophthalmoscopy, and no tissue samples could be collected. With the increasing number of
genetically affected dogs detected by DNA-testing, we were able to continue the questionnaires and
interviews initiated by Downs et al. The results strengthened the view that the disease in golden
retrievers (generally referred to as GR_PRA2) may indeed be similar to Bardet–Biedl syndrome (BBS)
in humans. To diagnose BBS patients corr ctly is often challengi g due to the heterogeneity of
the dise se with sympt ms that vary even b tween individual within families ca rying ide tical
mutations. In addition, the sympt ms overlap with ther diseases, such as Laurence–Moon syndrome,
which may in fact, to some extent be considered a variation of the same condition [69]. Polydactyly or
similar congenital digit abnormalities can be cues in the search for a correct diagnosis. In the absence
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of digit malformations, the relatively early onset of retinal degeneration [6,7], can guide clinicians
towards a BBS diagnosis. Both polydactyly and retinal degeneration are primary characteristics of BBS,
as well as obesity, kidney abnormalities, cognitive impairment, hypogonadism in males, and genital
abnormalities in females [7]. To date, 15 mutations in the human TTC8 gene have been reported to
cause BBS [2,17,70–76] (Table S6; Figure 7b). These mutations include six intronic splice-site variants,
as well as three exonic splice-site variants (one missense, one nonsense, and one silent mutation).
In addition, the identified mutations include three frameshift insertions/deletions, one complex variant,
one nonsense variant, and one non-frameshift deletion in the coding sequence. Moreover, one TTC8
splice-site variant has been associated with non-syndromic RP in humans [24]. Interestingly, one of the
exonic splice-site variants (NM_144596.3: c.1347G>C; p.Gln449His) has been reported to cause both
non-syndromic RP [77] and BBS [70], suggesting that the genetic background of each patient may play
a significant role in the development of BBS symptoms in humans. Similar to humans, the genetic
background is also likely to result in the heterogeneous clinical signs in dogs (Table S2).
All the dogs in this study were diagnosed with PRA initially causing visual problems in dim light,
later also under daylight conditions and eventually causing blindness. This is consistent with BBS,
where rod-cone dystrophy is the most frequently observed clinical sign, diagnosed in about 93% of the
patients with approximately three out of four becoming legally blind by the second to third decade of
life [6,7]. FERGs from the middle-aged female dog (GR02) showed bilateral loss of rod function, as well
as profoundly subnormal and delayed cone-amplitudes, supporting a diffuse rod-cone degeneration
(Figure 3). This is similar to human patients with TTC8 mutations, where loss of rod and cone function
has been reported [24,72,77]. Early in the course of the disease, human BBS patients may have cone
flicker responses with marked delays and near normal amplitudes that deteriorate over time [78].
Ttc8-knockout mouse models show both reduced rod and cone ERGs at an early age [79]. Interestingly,
the mouse models also demonstrate that cone structure, function, and viability depend on the normal
expression of Ttc8. Loss of the TTC8 protein results in shortened and disorganized photoreceptor outer
segments already before retinal maturation, as early as post-natal day 10 in Ttc8-knockout mice [79].
The lack of rhodopsin staining, and the appearance of truncated cone outer segments observed in the
retina of the affected female using fluorescence histochemistry (Figure 9), suggests that the deletion at
the TTC8 gene (TTC8delA) eventually results in a photoreceptor phenotype similar to the Ttc8-knockout
mice. Taken together, the progressive reduction of cone photoreceptors and concomitant decline of
cone ERGs may not only be secondary to degeneration of rods, as the TTC8 protein appears to be
essential for normal cone function.
We were able to investigate the retina of the affected female using OCT, and considerable outer
retinal thinning was observed (Figure 2), corroborating the results from ERG and postmortem findings.
The abnormal appearance and thinning of the INL was judged as secondary to the photoreceptor
degeneration. OCT-scans from the ventral (inferior) retina showed a more patchy degeneration with
irregular RPE lining, also reported in some human patients with BBS [80], and clusters of nuclei in the
ONL. Accumulation of lipofuscin, most clearly seen as increased autofluorescence in the non-tapetal
fundus (Figure 1) has also been reported in human patients with BBS. However, the precise distribution
of lipofuscin in the canine fundus is difficult to determine on cSLO because of the tapetal reflection in
this species.
In addition to retinal degeneration, both the clinically investigated siblings, as well as three
other affected dogs, were diagnosed with cataracts, a common secondary characteristic in human
BBS [78]. In contrast to the posterior polar cataracts typically seen in human patients, both the affected
male and the female developed cataracts that rather rapidly spread in the posterior, equatorial, and
anterior cortices. The cataracts contributed to the dogs’ visual impairment. The prevalence of posterior
polar cataracts in human BBS has been reported to be similar in patients with different genotypes,
although none of the patients studied was homozygous for pathogenic mutations in the TTC8 gene [81].
We cannot exclude that the cataracts of the affected dogs were secondary to the retinal degeneration,
because secondary cataracts are frequently seen in late-stage hereditary photoreceptor degenerations
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(PRA) in dogs [82]. Toxic dialdehydes from decaying photoreceptors have been proposed to induce
cataract formation [83] and the location of the cataractous changes in GR01 and GR02 in the more
metabolically active equatorial and cortical regions of the lenses may also suggest a toxic effect on
the lens. However, the cataracts in the golden retriever sib-pair were observed already at the initial
examination when the degeneration of the retinae was judged as moderately advanced.
The affected male was also diagnosed with iridociliary cysts (Figure 4a). Iridociliary cysts have
previously been reported in golden retrievers with glaucoma [84] and retinal detachments, but have
not been associated with progressive retinal degenerations. Our observation of iridociliary cysts in the
affected male is most likely a coincidental finding, but could possibly be a result of the deletion at the
TTC8 gene and a consequence of abnormal ciliary trafficking.
When Ansley et al. identified TTC8 as a novel BBS gene in 2003 [2], situs inversus was observed
in one of the patients with a TTC8 splice-site mutation. This led to the important conclusion that BBS
is a disease caused by ciliary dysfunction. The TTC8 protein is part of the BBSome, an octameric
protein complex which functions in the exit of activated G protein–coupled receptors (GPCRs) from
cilia [19,85,86]. Thus, the underlying cause of the syndrome is malfunction of primary cilia, an organelle
emanating from the cell surface of most mammalian cell types during growth arrest [87]. Primary cilia
function in cell signaling during development and in homeostasis, thus explaining the multitude of
organs affected in each BBS patient and the repertoire of different symptoms experienced. Nodal cilia,
a type of motile primary cilia transiently present during embryonal development, are crucial for
breaking the left-right symmetry during the embryogenesis, and defects in this process may cause
different forms of heterotaxy such as partial or total situs inversus, as well as congenital heart
defects [88,89]. Manifestation of situs inversus and other forms of heterotaxy is rare in the general
population (1/10,000). However, in a study of 368 participants in the Clinical Registry Investigating
Bardet–Biedl Syndrome (CRIBBS), six patients (1.6%) were found to have disorders of asymmetry,
suggesting a 170-fold increase compared to the general population [90]. Cardiovascular diseases and
congenital heart defects have also been reported for human BBS patients [7,91]. Of the 19 patients with
TTC8 mutations (Table S6), 3 were diagnosed with hypertension or haemophilia [2,72,76]. We therefore
investigated the cardiac status of the two affected golden retrievers. Both dogs showed normal cardiac
morphology, dimensions and motion, and a normal left-right body axis. In the postmortem gross
examination, a mild myxomatous valvular degeneration was seen in the heart tissue of the affected
male. While the finding is common in dogs [92], it has recently been shown that defects of the primary
cilia in the extra-cellular matrix can lead to myxomatous mitral valve disease in humans and mice [93].
Hypogonadism in males and genital abnormalities in females are considered primary
characteristics of human BBS [6,7]. Hypogonadism was also common for the male patients with TTC8
mutations (Table S6). The affected the males had a low total sperm count and a high number of abnormal
sperm cells, mainly lacking flagellum or having other tail-defects, indicating infertility (Figure 5a).
He did not display any interest in the female dog in heat at the time of sampling. The histopathological
examination of the testes revealed only a few elongated spermatids (Figure 5b). Severe sperm defects,
including tail abnormalities as well as a low total sperm count, have previously been reported in
Hungarian Puli dogs with a loss-of-function mutation in the Bardet–Biedl syndrome 4 (BBS4) gene [94].
The importance of BBS-genes for the normal formation of flagella in spermatogenesis has further
been shown in mouse models. Genetically modified mice for any of the genes Bbs1 [95], Bbs2 [96],
Bbs3 (Arl6) [97], Bbs4 [98], Bbs6 (Mkks) [99], or Bbs7 [100], result in failure to form normal flagella. In a
Bbs8-knockout mouse model, the sperm defects were not described, but the males were found to be
infertile [79].
Interestingly, many of these mouse models, including the Ttc8 knockout mouse [101], also showed
partial or complete anosmia. This is a secondary characteristic experienced by many BBS patients
in general [102], but it was not reported for the 19 human patients with TTC8 mutations. This is in
contrast with the present study, where most of the owners of the affected dogs (8/10) reported their
dogs having poor or gradually worsening sense of smell (Table S2). This appear to be a characteristic
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that is shared between dogs and mice, but not with humans. Moreover, as was the case for the dogs,
none of the mouse models exhibited polydactyly, and the phenotype of dogs may therefore resemble
the mouse phenotype more closely than that of human patients with TTC8 mutations.
Obesity was reported for 16 of the 19 human patients. Although we did not formally investigate
the body condition score for more than two dogs, the majority of them appeared overweight or heavy
according to the owners (Table S2). It should, however, be noted that we have not compared this to
the general golden retriever population. Similar to the two golden retriever siblings in this study,
dental anomalies were reported for one human patient with a TTC8 splice-site mutation [76] and for
27% of the BBS patients in general [7].
The histopathological changes in the right kidney of the affected male were most similar to a
renal dysplasia-like lesion (Figure 6). The female sibling had mild chronic bilateral glomerulonephritis,
but such mild chronic inflammatory changes are an unspecific finding, which probably did not affect
the animal clinically. In total, 4 of the 10 dogs included in this study had renal problems (Table S2),
suggesting that, as in humans, mutations in the TTC8 gene may result in variable renal phenotypes.
Among the 10 golden retrievers included in this study (Table S2), 1 dog was reported to be euthanized
due to kidney failure. Other reasons for euthanasia included gastrointestinal problems (2 dogs), as well
as problems related to sensory deprivation (visual and olfactory impairments: 2 dogs) and neoplastic
disease (1 dog). Interviews indicated a rather low average lifespan of the affected golden retrievers:
7 years and 8 months for the nine dogs in the questionnaires (one of the ten dogs is still alive as of
preparing this manuscript, 5 years of age). Data from 1995–2002 show that almost 90% of golden
retrievers survive to 8 years of age and more than 80% to the age of 10 [103]. The 1 bp deletion
in the canine TTC8 gene had detrimental effects on the dogs’ health and longevity. In human BBS
patients, kidney failure is a frequent cause of death and the average survival of the patients overall is
substantially reduced [104]. Taken together, the deletion in the canine TTC8 gene is associated with
additional clinical features apart from PRA in the affected dogs, such as obesity, renal and genital
anomalies, anosmia, short stature, and dental anomalies that are similar to human BBS.
The major isoforms of the TTC8 protein are predicted to consist of approximately 500 amino acid
residues, and the exon-intron structure is well conserved between human, dog, and mouse. Two canine
retinal transcripts were previously predicted to exist based on Sanger sequencing of cDNA by Downs
et al (2014) [1], one with and one without the retinal specific exon termed 2a. The transcript with the
retinal specific exon was originally reported in humans [24]. It was shown that an in-frame splice-site
mutation leading to the skipping of exon 2a is sufficient to cause a non-syndromic retinal degeneration
in humans. In mice, the retinal specific exon 2a was found to be exclusively expressed in the ocular
tissue, having the highest expression in the outer segments (OS) of both rod and cone photoreceptor
cells [24,105]. In addition to retinal photoreceptor cells, exon 2a has also been found expressed in
pinealocytes of rat pineal gland, and it has been suggested that these two cell types have evolved from
a common precursor photodetector cell [106]. In our study, we used Oxford Nanopore Sequencing
Technology for long-read sequencing, capable of reading through full-length transcripts and therefore
enhancing the detection of different splice sites. Notably, the data only gave support for three different
transcripts expressed in the retinal tissue (Figure 7), while the Ensembl annotation (release 100) predicts
the existence of seven canine transcripts, of which only one (ENSCAFT00000027700.5 corresponding
to tr2) was identified in this study. The six additional Ensembl canine transcripts are either skipping
exon(s): E5 (ENSCAFT00000043691.2), E6 (ENSCAFT00000050179.3), E5-6 (ENSCAFT00000093101.1),
E2a-10 (ENSCAFT00000070341.1), E1-2a (ENSCAFT00000086744.1), or E1-5 (ENSCAFT00000087482.1).
We found no evidence for the presence of these other transcripts in our data from the canine retina.
As expected, the tr2 transcript, which includes the retinal specific exon 2a, was found to be the
most highly expressed of the three identified transcripts. We also identified a short transcript (tr1)
without the retinal specific exon 2a, with low expression in the dog retina. In mice, despite having a
lower expression than the retinal specific transcript, the short transcript lacking the exon 2a is expressed
throughout the retinal cell layers and shows the highest expression in the RPE [24]. The retinal
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samples investigated in this study did not exclusively include photoreceptor cells, but also consisted of
other neural cells and RPE cells (Figure 8), which likely express the short transcript tr1. In addition
to these two previously identified canine retinal transcripts, we also found evidence for a third
transcript (tr3) including both exon 2a as well as a short exon with 22 nucleotides, here denoted 1b.
A transcript similar to tr3 is also reported in GenBank (XM_014115661.2), likely annotated by an ab
initio prediction detecting an open reading frame of sufficient length, but likely without supporting
alignment (The NCBI Eukaryotic Genome Annotation Pipeline; A translation initiation site (TIS) with
an optimal Kozak consensus sequence was identified in exon 1, but in tr3 this would extend an ORF
of 147 nucleotides over the exons 1b and 2a, and reach a stop codon in exon 2 (Figure 7). This short
transcript would likely be degraded by nonsense-mediated decay (NMD) [107]. If an alternative TIS
was used in exon 2, tr3 would be in-frame with the other transcripts and produce a protein product
of 455 amino acid residues featuring the complete TPR motif, which is involved in protein-protein
interaction [108]. It is yet to be defined if this transcript is translated into a protein product, and if its
expression is tissue specific.
The expression levels for all three TTC8 transcripts found in this study were markedly reduced in
the affected female dog. This was seen in the quantification of the cDNA sequencing data (Figure 8a–c),
but also by the lack of read coverage of transcripts mapping to the TTC8 locus in the dog reference
genome sequence when manually inspecting the data in IGV. The highest read depth in the locus was
13× (TPM = 16.8), while the read coverage for the two unaffected dogs (250–500×, TPM = 60.6 and 99.8,
respectively) was clearly higher than in the affected female. The reads detected in the affected dog
appeared to be only partly spliced and none of the reads reached full-length over all exons. The low
levels of TTC8 transcripts in the affected dog was further supported by RT-qPCR (Figure 8d). The data
suggested that the deletion in exon 7 (TTC8delA) and the subsequent premature stop codon in exon
8 lead to degradation of the TTC8 transcripts in the affected individual. To estimate the cell type
constitution of the samples, we also studied the expression levels of retinal marker genes in the affected
female compared to the two unaffected female dogs. As suggested by the histological sectioning of the
affected male retina (Figure S1) and the fluorescence histochemistry of the affected female (Figure 9),
the sequencing results showed a drastically lower expression of rod photoreceptor cell-specific genes,
and cone photoreceptor cell marker expression was only one third compared to the levels detected in
the two other dogs (Figure 8a–c, Table S4). The same pattern was observed in the RT-qPCR, where we
quantified the relative expression of RHO and OPN1LW genes (Figure 8d). The retinal degeneration of
both of these dogs (GR01 and GR02) was therefore likely advanced. BBSome deficiency has been shown
to cause defects in the transport of phototransduction proteins between the inner and outer segments of
the photoreceptors and, ultimately, these defects lead to photoreceptor cell death [96,109]. In addition
to aberrant photoreceptor marker gene expression, our data also suggested that the expression of
macroglial genes (Müller glia and astrocytes) was higher in the affected dog (Figure 8), most notably
clusterin (CLU) and glial fibrillary acidic protein (GFAP) expression (Table S4), both of which are known
to be upregulated under retinal stress and retinal degeneration [110–113].
5. Conclusions
The TTC8 gene encodes for one of the proteins forming the BBSome, and has in humans been
implicated in Bardet–Biedl syndrome (BBS). Long-read cDNA sequencing of non-affected dogs
suggested the expression of three retinal TTC8 transcripts and that the 1 bp deletion is a loss-of-function
mutation. Golden retriever dogs homozygous for the deletion develop an autosomal recessive form
of RP-like retinal degeneration (PRA), but it has hitherto been unclear if the affected dogs develop a
non-syndromic PRA or a syndromic ciliopathy similar to human BBS. In addition to PRA, we have
shown that the loss-of-function mutation indeed causes additional clinical features, such as obesity,
renal and genital anomalies, anosmia, short stature, and dental anomalies. We therefore conclude that
the deletion can result in a canine form of BBS. As in humans, BBS in dogs appear to be a heterogeneous
disorder with variable severity of clinical and morphological signs. A canine model for BBS may be of
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importance for novel therapeutic management of human patients. Canine models have successfully
been used to establish protocols for gene therapy of other inherited retinal diseases, and a TTC8-dog
model could potentially be developed to restore vision and improve the quality of life for BBS patients.
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